Iontophoresis in Psoriasis
NCT03979664 · Status: WITHDRAWN · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL
Last updated 2021-04-01
Summary
Iontophoresis potentially may be a good alternative to improved delivery of corticosteroids. Study Investigators propose to use iontophoresis to increase dexamethasone delivery into thick psoriasis plaques. The primary purpose of this study is to assess whether dexamethasone sodium phosphate iontophoresis is an effective local therapy for psoriasis. The objective of the study is to determine the efficacy of dexamethasone sodium phosphate iontophoresis for psoriasis.
Conditions
- Psoriasis
- Psoriasis Vulgaris
- Skin Diseases
Interventions
- DEVICE
-
Activapatch intellidose 2.5 using active Iontophoresis
Iontophoresis is a drug delivery system that uses electromigration and electro-osmosis to move charged molecules. Electromigration is the movement of ions across the skin by an electrical field. Positive ions move away from a cathode (positive charge) and towards an anode (negative charge). Negative ions move away from an anode and towards a cathode. Electro-osmosis is the volume movement of positive ions away from the opposite charge. Since skin is negatively charge, positively charged ions penetrate deep in the tissue from the negatively charged skin. 4 The use of iontophoresis was incorporated into medicine in efforts to increase the penetration of medications and avoid injection procedures. Dexamethasone sodium phosphate 4 mg/mL vial will be used in the study. Using a syringe, 2 cc of dexamethasone will be drawn and poured onto the designated medication site on the iontophoresis patch. Once the medication is poured, the patch will be applied on the skin and turned on.
- DEVICE
-
Activapatch intellidose 2.5 using inactive Iontophoresis
Iontophoresis is a drug delivery system that uses electromigration and electro-osmosis to move charged molecules. Electromigration is the movement of ions across the skin by an electrical field. Positive ions move away from a cathode (positive charge) and towards an anode (negative charge). Negative ions move away from an anode and towards a cathode. Electro-osmosis is the volume movement of positive ions away from the opposite charge. Since skin is negatively charge, positively charged ions penetrate deep in the tissue from the negatively charged skin. 4 The use of iontophoresis was incorporated into medicine in efforts to increase the penetration of medications and avoid injection procedures. Inactive medication will be used in the study. Using a syringe, 2 cc of inactive medication will be drawn and poured onto the designated medication site on the iontophoresis patch. Once the medication is poured, the patch will be applied on the skin and turned on.
- DRUG
-
Dexamethasone sodium phosphate 4 mg/mL vial will be used in the study. Using a syringe, 2 cc of dexamethasone will be drawn and poured onto the designated medication site on the iontophoresis patch. Once the medication is poured, the patch will be applied on the skin and turned on.
Sponsors & Collaborators
-
Wake Forest University Health Sciences
lead OTHER
Principal Investigators
-
Steven R Feldman, MD, Ph.D · Wake Forest University Health Sciences
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2021-03-31
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
- FDA Drug
- Yes
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Desoximetasone Spray 0.05%, 0.25%; Dose Ranging Study
NCT01018134 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Desoximetasone Spray 0.25% on Moderate to Severe Plaque Psoriasis
NCT01206387 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp Psoriasis
NCT02932462 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Psoriasis With Parathyroid Hormone
NCT00007306 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
DFD01 Spray vs Comp01 Lotion HPA Axis Suppression Study in Patients With Moderate to Severe Plaque Psoriasis
NCT02070965 ·Status: COMPLETED ·Phase: PHASE2
-
Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis
NCT00769184 ·Status: COMPLETED ·Phase: NA
-
MED in UVB Devices in the Presence and Absence of UV Filter
NCT03049319 ·Status: WITHDRAWN ·Phase: NA
-
Onercept in the Treatment and Re-Treatment of Subjects With Moderate to Severe Plaque Psoriasis
NCT00090129 ·Status: TERMINATED ·Phase: PHASE3
-
Trial to Assess the Potency of SOR007 Ointment in a Psoriasis Plaque Test
NCT03004339 ·Status: COMPLETED ·Phase: PHASE1
-
Topical PH-10 Aqueous Hydrogel and Photodynamic Therapy for Psoriasis
NCT00555646 ·Status: TERMINATED ·Phase: PHASE2
-
Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis
NCT02515097 ·Status: COMPLETED ·Phase: PHASE3
-
Etanercept With Tacrolimus for Psoriasis
NCT00134394 ·Status: COMPLETED ·Phase: PHASE2
-
Phase III Clinical Study in Patients With Mild to Severe Scalp Psoriasis
NCT02933866 ·Status: COMPLETED ·Phase: PHASE3
-
Moderate to Severe Plaque Psoriasis With Scalp Involvement
NCT00791765 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of IDP-122 in the Treatment of Participants With Plaque Psoriasis
NCT02514577 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis
NCT02274792 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of DLX105-DMP in Subjects With Plaque Psoriasis
NCT04203433 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety of 0.25% Desoximetasone Cream (Topoxy®) in the Treatment of Scalp Psoriasis
NCT02749656 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study to Determine the Efficacy of Taclonex Topical Suspension as a Supplement to Non-biologic Systemic Therapy
NCT01761019 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Assess the Potential for Adrenal Suppression Following Treatment With DSXS in Patients With Plaque Psoriasis
NCT02601469 ·Status: COMPLETED ·Phase: PHASE2
-
To Demonstrate the Superior Efficacy of NYC 0462 Ointment Over That of the Placebo in the Treatment of Plaque Psoriasis
NCT00747032 ·Status: WITHDRAWN ·Phase: PHASE3
-
An Observational Study to Assess Patient Satisfaction and Control of Psoriasis With Calcipotriene/Betamethasone Dipropionate (Taclonex®) Topical Suspension, and Effect on Quality of Life
NCT01982552 ·Status: COMPLETED
-
Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis
NCT06723171 ·Status: SUSPENDED ·Phase: PHASE2
-
A Study of the Efficacy and Safety of DFD-06 Cream in the Treatment of Moderate to Severe Plaque Psoriasis
NCT02635204 ·Status: COMPLETED ·Phase: PHASE3
-
Once-Weekly Oral Aminopterin for the Treatment of Subjects With Moderate-To-Severe Psoriasis
NCT03431974 ·Status: COMPLETED ·Phase: PHASE2